文献速递骨肌介入US

超声引导下射频消融治疗莫顿神经瘤的初步经验

Ultrasound-guided radiofrequency ablation for treatment of Morton's neuroma: initial experience.
PubMed 文献 · Clin Radiol · 2019-08-10

本研究评估超声引导下射频消融治疗有症状的莫顿神经瘤的疗效与安全性,22个神经瘤接受治疗,8周和8个月随访时VAS评分均较前显著降低,8个月时89%患者满意,无显著不良反应。

要点

  • 超声引导下射频消融可作为有症状莫顿神经瘤在手术前的治疗选择。
  • 术后8周VAS较术前显著降低(p<0.001),8个月较8周进一步显著降低(p=0.008)。
  • 8个月时89%患者对疗效满意,无显著不良反应。

核心结论

  • 超声引导下射频消融治疗有症状的莫顿神经瘤安全,初步疗效良好。
  • 长期结局及与其他治疗方案的比较仍需进一步研究以确立其治疗地位。

研究设计与样本

  • 单臂初步经验研究,纳入有症状的足部莫顿神经瘤患者,在考虑手术前转诊接受射频消融治疗。
  • 所有神经瘤均经超声成像证实,并接受过包括矫形支具和/或类固醇注射的保守治疗。
  • 超声引导下射频消融在局部麻醉下作为门诊操作完成,随访时间为8周和8个月。
  • 结局评估采用视觉模拟量表(VAS)评分、Manchester-Oxford足踝问卷、患者总体满意度和并发症。

诊断标准与关键数值

  • VAS评分术后8周较术前显著降低(p<0.001,Wilcoxon符号秩检验)。
  • VAS评分术后8个月较8周显著降低(p=0.008,Wilcoxon符号秩检验)。
  • 8个月时89%接受治疗的患者对操作结果满意。
  • 未记录到显著不良反应。

临床应用与阅片要点

  • 超声可用于证实莫顿神经瘤并引导射频消融操作。
  • 原文未据此给出推荐。

局限性

  • 原文结论指出需要进一步研究长期结局。
  • 原文结论指出需要进一步研究与其他管理方案的比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To assess the efficacy and safety of ultrasound-guided radiofrequency ablation (RFA) for treatment of symptomatic Morton's neuroma.

MATERIALS AND METHODS: Patients with symptomatic Morton's neuroma of the foot were referred for treatment with RFA, prior to consideration for surgery. All neuromas were proven by ultrasound imaging and had a trial of conservative management including orthotic support and/or steroid injections. Ultrasound-guided RFA was performed as an outpatient procedure under local anaesthetic. Patients were followed up at 8 weeks and 8 months. Outcomes were assessed with a visual analogue scale (VAS) score, Manchester-Oxford Foot and Ankle Questionnaire, overall patient satisfaction, and complications.

RESULTS: Twenty-two neuromas were treated with RFA under ultrasound guidance. The VAS score at 8 weeks was significantly lower than the VAS score pre-procedure (p<0.001, Wilcoxon signed ranks test) and the VAS score at 8 months was significantly lower than the VAS score at 8 weeks (p=0.008, Wilcoxon signed ranks test). At 8 months, 89% of treated patients were satisfied with the procedure outcome. No significant adverse effects were recorded.

CONCLUSION: Ultrasound-guided RFA is safe, with excellent initial results in treatment of symptomatic Morton's neuroma. Further studies on long-term outcomes and comparison to other management options will be required to establish its role in management of symptomatic Morton's neuroma.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Shah R, Ahmad M, Hanu-Cernat D, et al. Ultrasound-guided radiofrequency ablation for treatment of Morton's neuroma: initial experience. Clin Radiol. 2019. PMID: 31409448. doi:10.1016/j.crad.2019.07.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。